AMY YORK: Open Payments
NPI 1811013832 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 69 payments from 33 companies in 2025. Trend: 2023 $1,390 · 2024 $1,436 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Eisai Inc. | 6 | $136 |
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| PFIZER INC. | 5 | $91 |
| Daiichi Sankyo Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| BeOne Medicines USA, Inc. | 3 | $80 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| ABBVIE INC. | 4 | $77 |
| Legend Biotech USA Inc. | 3 | $73 |
Products named: Lenvima, Enhertu, OJJAARA, BRUKINSA, KEYTRUDA, CARVYKTI, Wegovy, EPKINLY.
Industry payments across GA — which companies pay providers there.
